Association Between Infection and Thrombosis After Coronary Artery Bypass Grafting: A Cohort Study

Xiaojie Liu1, Lijuan Wang1, Sudena Wang1

  • 1Department of Anesthesiology, State Key Laboratory of Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

Postoperative infection after coronary artery bypass grafting (CABG) significantly increases the risk of perioperative thrombosis. While infection did not elevate major adverse cardiovascular and cerebral events (MACCEs), it highlights a critical area for quality improvement in cardiac surgery care.

Area of Science:

  • Cardiovascular Surgery
  • Infectious Disease Epidemiology
  • Thrombosis Research

Background:

  • Surgery-related infection is a significant complication in cardiac surgery.
  • The relationship between postoperative infection and thrombosis after coronary artery bypass grafting (CABG) requires further investigation.

Purpose of the Study:

  • To investigate the association between postoperative infection and thrombosis.
  • To examine the link between postoperative infection and major adverse cardiovascular and cerebral events (MACCEs) in CABG patients.

Main Methods:

  • Retrospective cohort study including 75 infected patients and 2,926 controls undergoing CABG.
  • Analysis of perioperative and postoperative data using multivariable regression.

Main Results:

  • Postoperative infection was associated with a 5.13-fold increased odds of perioperative thrombosis (p < 0.0001).
  • No significant association was found between infection and 5-year MACCEs (p = 0.080).
  • Older age was a significant risk factor for MACCEs (HR 1.040, p < 0.0001).

Conclusions:

  • A clear association exists between postoperative infection and perioperative thrombosis following CABG.
  • Identifying and managing infection risk factors can improve patient outcomes and reduce thrombosis complications.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.6K